Skip to content

Pithécanthrope: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Pithécanthrope

BE 0777.588.028
NACE 86.910, Medical imaging and medical laboratories
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€13,815
2024 · €17,579-€3,764
Equity
€31,812
2024 · €17,997+€13,815
Cash
€5,282
2024 · €1,600+€3,682
Balance sheet total
€46,546
2024 · €24,620+€21,926

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€18,153

    up €18,153 (+80.8%), from €22,478 to €40,631

    of which Trade receivables: +€17,325

  • Cash +€3,682

    up €3,682 (+230.2%), from €1,600 to €5,282

    mainly Net result for the year (+€13,815) and Other debts (+€6,341)

Equity and liabilities
  • Reserves +€25,000

    new in 2025: €25,000

  • Profit (loss) carried forward -€11,185

    down €11,185 (-74.6%), from €14,997 to €3,812

  • Other debts +€6,341

    new in 2025: €6,341

  • Trade debts +€1,770

    up €1,770 (+258.7%), from €684 to €2,454

Income statement
  • Gross operating margin -€4,484

    down €4,484 (-18.7%), from €24,024 to €19,540

  • Taxes -€970

    down €970 (-16.3%), from €5,939 to €4,969

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €17,579
Gross operating margin -€4,484
Other operating charges -€234
Financial income -€6
Financial charges -€10
Taxes +€970
Result 2025 €13,815

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€3,682
Investment €0
Financing €0
Cash 2024 €1,600
Net result for the year +€13,815
Receivables within one year -€18,153
Deferred charges and accrued income -€91
Trade debts +€1,770
Other debts +€6,341
Cash 2025 €5,282
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €24,620 €46,546 +€21,926 +89.1%
Current assets 29/58 €24,620 €46,546 +€21,926 +89.1%
Amounts receivable within one year 40/41 €22,478 €40,631 +€18,153 +80.8%
Trade receivables 40 €22,275 €39,600 +€17,325 +77.8%
Other amounts receivable 41 €203 €1,031 +€828 +407.5%
Cash at bank and in hand 54/58 €1,600 €5,282 +€3,682 +230.2%
Deferred charges and accrued income 490/1 €542 €633 +€91 +16.8%
Total equity and liabilities 10/49 €24,620 €46,546 +€21,926 +89.1%
Equity 10/15 €17,997 €31,812 +€13,815 +76.8%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 - €25,000 +€25,000
Distributable reserves 133 - €25,000 +€25,000
Profit (loss) carried forward 14 €14,997 €3,812 -€11,185 -74.6%
Amounts payable 17/49 €6,623 €14,734 +€8,111 +122.5%
Amounts payable within one year 42/48 €6,623 €14,734 +€8,111 +122.5%
Trade debts 44 €684 €2,454 +€1,770 +258.7%
Suppliers 440/4 €684 €2,454 +€1,770 +258.7%
Taxes, remuneration and social security 45 €5,939 €5,939 = 0.0%
Taxes 450/3 €5,939 €5,939 = 0.0%
Other amounts payable 47/48 - €6,341 +€6,341
Other operating charges 640/8 €387 €622 +€234 +60.5%
Gross operating margin 9900 €24,024 €19,540 -€4,484 -18.7%
Operating profit (loss) 9901 €23,636 €18,918 -€4,718 -20.0%
Financial income 75/76B €6 €0 -€6 -100.0%
Recurring financial income 75 €6 €0 -€6 -100.0%
Financial charges 65/66B €125 €135 +€10 +8.0%
Recurring financial charges 65 €125 €135 +€10 +8.0%
Profit (loss) for the period before taxes 9903 €23,518 €18,784 -€4,734 -20.1%
Income taxes 67/77 €5,939 €4,969 -€970 -16.3%
Profit (loss) for the period 9904 €17,579 €13,815 -€3,764 -21.4%
Profit (loss) for the period to be appropriated 9905 €17,579 €13,815 -€3,764 -21.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.